The Director will joint motivated and newly formed Regulatory Science & Pharmaco-vigilance (RSP) business unit aiming at brining regulatory innovation in drug development and commercialization.
The RSP aims to maximize opportunities for product approval, its safe use and further development by:
The director regulatory strategy CMC is responsible for overseeing the development and implementation of global regulatory CMC strategies for product development and commercialization. He/she will provide regulatory CMC leadership across projects, teams and committees and will provide strategic and operational leadership for regulatory CMC activities including submission applications and health authority interactions.
The position reports to the Vice President of Regulatory Science & Pharmaco-vigilance business unit.